NSC |
Compound |
Enrichment |
Correlation |
NSC 744331 |
(2R,11aS)-8- {2-[4-(2-{[(2R,11aS)-C2-di-Fluoro-7-Methoxy-5-oxo-2,3,5,11a-tetrahydro-1-H-benzo[e]-pyrrolo[1,2-a][1,4]diazepine-8-yl}propyl)piperazino]propoxy}-C2-di-fluoro-7-Methoxy-2,3,5,11a-tetrahyd |
0.000572036815736153 |
0.34254217 |
NSC 208652 |
2,4-Quinazolinediamine, 5-chloro-6-[[(3,4-dichlorophenyl)amino]methyl]- |
0.000601164336889762 |
0.80784826 |
NSC 368891 |
Null |
0.000601164336889762 |
0.48001461 |
NSC 621486 |
2-Propen-1-one, 1-(1,4-dioxo-2,6,7-trimethylquinoxalin- 3-yl)-3-(2-nitrophenyl)- |
0.000601164336889762 |
-0.21382378 |
NSC 717066 |
Null |
0.000601164336889762 |
0.3410316 |
NSC 717833 |
Null |
0.000601164336889762 |
0.11046666 |
NSC 722900 |
N-(3-Iodo-1-propyl)-5,6-dihydro-2,3-dimethoxy-8,9-methylened ioxy-5,11-dioxo-11H-indeno-[1,2-c]isoquinoline |
0.000601164336889762 |
0.63755731 |
NSC 740268 |
Indenoisoquinoline derivative |
0.000601164336889762 |
0.64114401 |
NSC 762555 |
Null |
0.000601164336889762 |
-0.35660864 |
NSC 287459 |
Cytarabine AY |
0.000614175706312789 |
0.59901069 |